Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The Middle East and Africa have many hard-to-treat cardiac patients. This is transforming the IHD industry. Ischemic heart disease—including coronary artery disease—is the leading cause of illness and death. That's why people are working to prevent and cure it better.
Growing rates of ischemic heart disease risk factors such high blood pressure, diabetes, obesity, and inactivity harm the market. As individuals move to towns and change their lifestyles, more people have these risk factors. This requires more comprehensive treatment, diagnosis, and prevention methods.
As invasive cardiology improves, the market shifts. New minimally invasive, stent, and percutaneous coronary procedures improve ischemic heart disease outcomes. Better cardiovascular treatments are being employed locally.
Ischemic heart disease is becoming more common in younger individuals. More awareness and open-heart screening programs make it simpler to identify at-risk or early-stage heart disease patients and start treatment immediately.
Heart ultrasounds are being utilized to detect ischemic heart disease. Ultrasound, nuclear imaging, and cardiac MRI are increasingly employed to see the heart's anatomy and functioning. This aids physicians' diagnosis and therapy. The way markets work is changing because of technology, especially when it comes to heart disease caused by lack of blood flow. Video chats and being able to watch heart patients from away are all made possible by telemedicine. This makes it easier for people to get heart care, especially in places that are hard to get to or don't have enough doctors.
Secondary defense methods are getting more and more attention as a way to treat ischemic heart disease. For people who already have ischemic heart disease, changing their lifestyle, going to cardiac treatment, and taking medicine to lower their risk factors are all very important ways to keep things from happening again and make their long-term prospects better.
The IHD market is changing because healthcare is becoming more and more focused on the person. Doctors treat ischaemic heart disease by making treatment plans that are unique to each patient and take their needs and preferences into account. Also, they are telling people to make choices together.
Heart medicine modifications by the pharmaceutical industry are transforming the market. Current research and development aims to identify novel ischemic heart disease treatments. These medications may be antiplatelet, lipid-lowering, or hypertensive.
Things are getting better, but the Middle East and Africa still have trouble with healthcare centers and getting to them. It is still being worked on by putting money into health care centers, programs that train health care workers, and projects that make it easier for people in underserved places to get heart care.
MEA Ischemic Heart Disease Market Highlights:
Middle-East and Africa Ischemic Heart Disease Market Overview
Middle-East and Africa Ischemic Heart Disease Market Size was valued at USD 1.90 Billion in 2023. The MEA Ischemic Heart Disease industry is projected to grow from USD 2.30 Billion in 2024 to USD 4.30 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.70% during the forecast period (2024 - 2032).
Ischemic heart disease, also known as Coronary Artery Disease, is a condition that affects the supply of blood to the heart. The blood vessels are narrowed or blocked due to the deposition of cholesterol on their walls. The prevalence of coronary heart disease is promoted in turn by a high prevalence of cardiovascular risk factors, particularly smoking, hypertension, dyslipidemia, diabetes, and sedentary lifestyles. Countries in Middle East and Africa bear a heavy burden from Ischemic heart disease.
According to, Dubai Health Authority, Heart disease is the cause for every 3 in 10 deaths in the UAE. Huge funding in R&D and various initiatives by government are driving the growth for Ischemic heart Disease market in Middle East and Africa. Middle-East and Africa Ischemic heart Disease market is growing steadily.
Study objectives of Middle-East and Africa Ischemic Heart Disease Market:
- To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the Middle-East and Africa Ischemic heart disease market
- To provide insights about factors affecting the market growth
- To analyze the Middle-East and Africa Ischemic heart Disease market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
- To provide historical and forecast revenue of the market segments and sub-segments with respect to two main geographies and their countries- Middle East & Africa.
- To provide country level analysis of the market with respect to the current market size and future prospective
- To provide country level analysis of the market for segments by type, by diagnosis, by treatment type and its sub-segments.
- To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
- To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Middle-East and Africa Ischemic heart Disease market.
Middle-East and Africa Ischemic Heart Disease Market Segments
Middle-East and Africa Ischemic heart Disease market has been segmented on the basis of type which comprise stable angina, unstable angina, myocardial infarction, and Others.
On the basis of diagnosis the market is segmented into (Electrocardiogram, Echocardiography, Stress Testing, Coronary angiography, Magnetic resonance imaging (MRI), Chest X Ray, and Others.
On the basis of treatment type market is segmented into Medications, Surgery, Lifestyle changes, and others.
Key Players for Middle-East and Africa Ischemic Heart Disease Market
Some of the key players in this market are:
- King Faisal Specialist Hospital and Research Centre (Saudi Arabia)
- Riyadh Military Hospital (Saudi Arabia)
- Hamad Medical Corporation (Qatar)
- American Hospital Dubai
- Ganzouri Specialized Hospital (Egypt)
- AstraZeneca (U.K.)
- Sanofi (France)
- Merck Sharp & Dohme Corp.(U.S.)
- AUM Cardiovascular (US)
- HeartWare (U.S.)
Intended Audience:
- Middle-East and Africa Ischemic heart disease Equipment manufacturers
- Middle-East and Africa Ischemic heart disease Equipment Suppliers
- Government and Independent Regulatory Authorities
- Research and Development (R&D) Companies
- Independent Research Laboratories
- Market Research and Consulting Service Providers
- Medical Research Laboratories
Regional Analysis of Middle-East and Africa Ischemic heart Disease Market
Considering the Middle-East and Africa Ischemic heart Disease Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Ischemic heart Disease. Moreover Saudi Arabia market is also growing and second largest market for Ischemic heart disease. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Ischemic heart Disease during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.
The report for Middle-East and Africa Ischemic heart Disease market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
